The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications

被引:0
|
作者
Steffen M. Heckl
Viva Wiesener
Hans-Michael Behrens
Dita Ulase
Sandra Krüger
Christoph Röcken
机构
[1] Christian-Albrechts-University,Department of Pathology
[2] University Hospital Schleswig–Holstein,Department of Internal Medicine I
[3] Riga Stradins University,Department of Pathology
来源
Gastric Cancer | 2019年 / 22卷
关键词
Gastric cancer; Insulin receptor; HER-2 Proto-Oncogene Protein; Prognosis; Cancer treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1130 / 1142
页数:12
相关论文
共 50 条
  • [31] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [32] Central validation of HER2 status to determine heterogeneity of marker expression in HER2-positive gastric cancer (GC).
    Haffner, Ivonne
    Luber, Birgit
    Maier, Dieter
    Kretzschmar, Albrecht
    von Weikersthal, Ludwig Fischer
    Ahlborn, Miriam
    Riera-Knorrenschild, Jorge
    Rau, Beate
    Weissinger, Florian
    Fuxius, Stefan
    Neumann, Steffen
    Decker, Thomas
    Schierle, Katrin
    Wittekind, Christian
    Lordick, Florian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [33] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
  • [34] Is “liquid biopsy” useful for assessing HER2 status in gastric cancer?
    Hideaki Shimada
    Journal of Gastroenterology, 2015, 50 : 119 - 120
  • [35] Assessment of HER2 status in resected gastric cancer in European population
    Lago Nieves, Martinez
    Nallib Ihab, Abdulkader
    Santamaria Dora, Insua
    Nunez Patricia, Viano
    Juan Jose, Carrera
    Jose Ramon, Antunez Lopez
    Maria Elena, Padin Iruegas
    Rafael, Lopez
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients?
    Pirrelli, M.
    Caruso, M. L.
    Di Maggio, M.
    Armentano, R.
    Valentini, A. M.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (02) : 397 - 404
  • [37] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
  • [38] HER2 STATUS IN OESOPHAGOGASTRIC JUNCTION AND GASTRIC CANCER - THE IRISH LANDSCAPE
    Jayaram, A.
    Battley, J. E.
    Teo, M. Y.
    Rahman, R. Abdul
    Bambury, R.
    Bennett, M. W.
    Sheehan, M. Margaret
    McDermott, R.
    Power, D. G.
    Leonard, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 248 - 248
  • [39] Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients?
    M. Pirrelli
    M. L. Caruso
    M. Di Maggio
    R. Armentano
    A. M. Valentini
    Digestive Diseases and Sciences, 2013, 58 : 397 - 404
  • [40] HER2 status of advanced gastric cancer is similar in europe and asia
    Lordick, F.
    Leon-Chong, J.
    Kang, Y.
    Park, S.
    Bang, Y.
    Sawaki, A.
    Van Cutsem, E.
    Sloss, O.
    Jordan, B.
    Feyereislova, A.
    ANNALS OF ONCOLOGY, 2007, 18 : VII95 - VII96